SCHEMBL4047168

SCHEMBL4047168

CCCN(CCCCl)C1Cc2ccccc2C1

nearest known ligand 0.77

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 4/20 0.77
▸ DRD2 P14416 1/20 0.65
▸ HTR1A P08908 1/20 0.62
▸ FYN P06241 1/20 0.50
▸ SIGMAR1 Q99720 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8688812 0.88 DRD3 (1.00) DRD3DRD2HTR1AFYNSIGMAR1
SCHEMBL28699255 0.84 DRD3 (0.77) DRD3DRD2HTR1AFYN
SCHEMBL29362760 0.83 DRD3 (0.75) DRD3DRD2HTR1A
SCHEMBL16299407 0.81 DRD3 (0.85) DRD3DRD2HTR1AFYNSIGMAR1
SCHEMBL11198430 0.78 DRD2 (0.84) DRD3DRD2HTR1A
SCHEMBL28699254 0.77 DRD3 (0.65) DRD3DRD2HTR1A
SCHEMBL31558065 0.77 HTR1A (1.00) DRD3DRD2HTR1A
SCHEMBL9359278 0.77 HTR1A (1.00) DRD3DRD2HTR1A
SCHEMBL11147712 0.76 DRD2 (0.84) DRD3DRD2HTR1A
SCHEMBL9094473 0.76 HTR1B (0.62) DRD3DRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140908-B1 TRIAZOLE COMPOUNDS WITH DOPAMINE-D3-RECEPTOR AFFINITY ABBOTT GMBH & CO KG (DE) 2009-03-04 — — EP disclosed
US-6579892-B1 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole ABBOTT LABORATORIES 2003-06-17 — — US disclosed
EP-1140908-A1 TRIAZOLE COMPOUNDS WITH DOPAMINE-D3-RECEPTOR AFFINITY BASF AKTIENGESELLSCHAFT (DE) 2001-10-10 — — EP disclosed
WO-2000042038-A1 TRIAZOLE COMPOUNDS WITH DOPAMINE-D3-RECEPTOR AFFINITY BASF AKTIENGESELLSCHAFT (DE) 2000-07-20 — — WO disclosed
Send feedback